{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:19:04Z","timestamp":1781889544830,"version":"3.54.5"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135941","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T17:56:42Z","timestamp":1441994202000},"page":"e0135941","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy"],"prefix":"10.1371","volume":"10","author":[{"given":"Masako","family":"Nishizawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiichiro","family":"Shiino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Matano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Heneine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.315.7117.1194","article-title":"Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study","volume":"366","author":"JA Sterne","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/13543784.2012.661713","article-title":"Dolutegravir for the treatment of HIV","volume":"21","author":"C Katlama","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"JM Coffin","year":"1995","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virusres.2007.12.021","article-title":"HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo","volume":"134","author":"J Martinez-Picado","year":"2008","journal-title":"Virus Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/496984","article-title":"Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis","volume":"41","author":"PE Sax","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1089\/aid.2006.0310","article-title":"Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz","volume":"23","author":"K Borroto-Esoda","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/528802","article-title":"Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects","volume":"197","author":"DR Kuritzkes","year":"2008","journal-title":"J Infect Dis"},{"key":"ref9","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. (2014) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Available: http:\/\/aidsinfonihgov\/ContentFiles\/AdultandAdolescentGLpdf<\/ext-link>."},{"key":"ref10","first-page":"120","article-title":"Analysis of heterogeneous viral populations by direct DNA sequencing","volume":"15","author":"T Leitner","year":"1993","journal-title":"Biotechniques"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/aid.1998.14.869","article-title":"Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples","volume":"14","author":"HF Gunthard","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2010.10.001","article-title":"Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naive patients","volume":"50","author":"KJ Metzner","year":"2011","journal-title":"J Clin Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jviromet.2007.06.012","article-title":"Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations","volume":"146","author":"R Paredes","year":"2007","journal-title":"J Virol Methods"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1371\/journal.pone.0000638","article-title":"Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations","volume":"2","author":"JA Johnson","year":"2007","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jviromet.2009.11.025","article-title":"Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design","volume":"164","author":"VF Boltz","year":"2010","journal-title":"J Virol Methods"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/JCM.36.2.569-572.1998","article-title":"Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine","volume":"36","author":"RE Edelstein","year":"1998","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e10952","DOI":"10.1371\/journal.pone.0010952","article-title":"Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naive subjects in the CASTLE study","volume":"5","author":"M Lataillade","year":"2010","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jviromet.2011.08.020","article-title":"Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit","volume":"178","author":"E Stelzl","year":"2011","journal-title":"J Virol Methods"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/JCM.02652-12","article-title":"Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory","volume":"51","author":"B Avidor","year":"2013","journal-title":"J Clin Microbiol"},{"key":"ref20","article-title":"Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure","author":"S Mohamed","year":"2014","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e86771","DOI":"10.1371\/journal.pone.0086771","article-title":"Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure","volume":"9","author":"MA Vandenhende","year":"2014","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1086\/430742","article-title":"Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012","volume":"192","author":"T Flys","year":"2005","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/430741","article-title":"Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated","volume":"192","author":"JA Johnson","year":"2005","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1073\/pnas.0602033103","article-title":"Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission","volume":"103","author":"S Palmer","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes","volume":"199","author":"BB Simen","year":"2009","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/651136","article-title":"Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy","volume":"201","author":"KJ Metzner","year":"2010","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1128\/JVI.02582-10","article-title":"Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants","volume":"85","author":"S Gianella","year":"2011","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e28952","DOI":"10.1371\/journal.pone.0028952","article-title":"Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection","volume":"6","author":"JD Stekler","year":"2011","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2010.07.008","article-title":"Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008","volume":"88","author":"J Hattori","year":"2010","journal-title":"Japan. Antiviral Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e83150","DOI":"10.1371\/journal.pone.0083150","article-title":"Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan","volume":"8","author":"M Nishizawa","year":"2013","journal-title":"PLoS One"},{"key":"ref31","unstructured":"Stanford HIV Drug Resistance Database. Available: http:\/\/sierra2.stanford.edu\/sierra\/servlet\/JSierra<\/ext-link>."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular Evolutionary Genetics Analysis version 6.0","volume":"30","author":"K Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"ref33","article-title":"Molecular Evolution and Phylogenetics","author":"M Nei","year":"2000"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/QAD.0b013e3283034953","article-title":"Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy","volume":"22","author":"O Peuchant","year":"2008","journal-title":"AIDS"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/jac\/dkr291","article-title":"Transmission dynamics of the M184V drug resistance mutation in primary HIV infection","volume":"66","author":"MA Wainberg","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/infdis\/jit310","article-title":"Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection","volume":"208","author":"KJ Metzner","year":"2013","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1386-6532(01)00231-1","article-title":"Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy","volume":"24","author":"D Albrecht","year":"2002","journal-title":"J Clin Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/00002030-200306130-00009","article-title":"Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptions","volume":"17","author":"P Halfon","year":"2003","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/QAD.0b013e3280121ac6","article-title":"Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients","volume":"21","author":"KJ Metzner","year":"2007","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e21734","DOI":"10.1371\/journal.pone.0021734","article-title":"Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection","volume":"6","author":"KJ Metzner","year":"2011","journal-title":"PLoS One"},{"key":"ref41","first-page":"672","article-title":"Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients","volume":"201","author":"EK Halvas","year":"2010","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcv.2010.03.017","article-title":"Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART","volume":"48","author":"IJ MacLeod","year":"2010","journal-title":"J Clin Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy","volume":"5","author":"JA Johnson","year":"2008","journal-title":"PLoS Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and-adherent patients","volume":"48","author":"KJ Metzner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e21655","DOI":"10.1371\/journal.pone.0021655","article-title":"Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure","volume":"6","author":"P Delobel","year":"2011","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis","volume":"305","author":"JZ Li","year":"2011","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAD.0b013e3283427dcb","article-title":"Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy","volume":"25","author":"DD Goodman","year":"2011","journal-title":"AIDS"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virol.2012.01.002","article-title":"Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients","volume":"426","author":"P Messiaen","year":"2012","journal-title":"Virology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e36494","DOI":"10.1371\/journal.pone.0036494","article-title":"Low-cost ultra-wide genotyping using Roche\/454 pyrosequencing for surveillance of HIV drug resistance","volume":"7","author":"DM Dudley","year":"2012","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T06:20:01Z","timestamp":1599546001000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135941"}},"subtitle":[],"editor":[{"given":"Nicolas","family":"Sluis-Cremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,11]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135941","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,11]]}}}